BPA Call 36C24122A0144-36C24124N0596
- This federal contract award to Luminex Corporation is for the delivery of Luminex reagents under a Blanket Purchase Agreement (BPA) call. The contract, with a ceiling value of $164,760.47, was awarded on August 1, 2021 by the Veterans Integrated Service Network 1 (VISN 1), a division of the Department of Veterans Affairs (VA). The contract is not set aside and is for COVID-19 related requirements, as indicated by the National Interest Action Code. Luminex is a manufacturer of biological...
- This federal contract award is for LUMINEX REAGENTS, provided to the Veterans Integrated Service Network 1 (VISN 1) of the U.S. Department of Veterans Affairs. The $89,432.32 firm fixed price contract was awarded to Luminex Corp, a manufacturer of in-vitro diagnostic testing technologies, on August 1, 2023. The contract is a Blanket Purchase Agreement (BPA) call under the GSA Schedule for In-Vitro Diagnostics, Reagents, and Test Kits. The contract has no set-aside designation and is expected...
- This is a federal contract award from the Veterans Integrated Service Network 1 (VISN 1), a civilian agency, to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract, valued at $95,000.00, is for the provision of LUMINEX REAGENTS. It is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type and an ultimate completion date of July 31, 2026. The contract is not designated as a set-aside. Luminex Corp, the prime contractor,...
- Luminex Corporation was awarded a $54,542.40 firm fixed price blanket purchase agreement call against the General Services Administration Federal Supply Schedule contract for Invitro Diagnostics, Reagents, Test (FSS-65-VII). The contract calls for the delivery of reagents and consumables for Luminex multiplexing technology to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1, with performance taking place in North Providence, Rhode Island. No...
- Luminex Corporation was awarded a $91,000 firm fixed price Blanket Purchase Agreement (BPA) call contract by the Department of Veterans Affairs (VA) to provide Verigene brand reagents and supplies to the Rocky Mountain Regional VA Medical Center in Austin, Texas. The contract was awarded on October 1, 2019 under the VA's Master GSA Schedule for In Vitro Diagnostics, Reagents, and Tests, and has a period of performance through September 30, 2020. No set-aside designation was applied to this BPA...
- Luminex Corporation was awarded a $90,282 firm fixed price contract by the Department of Veterans Affairs to provide VERIGENE brand reagents and supplies to the Rocky Mountain Regional VA Medical Center in Austin, Texas. The contract was awarded on October 1, 2020 under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, with an end date of September 30, 2021. As the prime contractor, Luminex will deliver test kits and related materials to support clinical operations at the VA...
- Luminex Corporation was awarded a $463,944.32 delivery order against the General Services Administration (GSA) Schedule contract for Invitro Diagnostics, Reagents, Test (FSS-65-VII) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1. The firm fixed price order is for the delivery of Luminex SAR2 test kits to support COVID-19 testing efforts and has a period of performance through November 11, 2021. No set-aside designation was used for this...
- This federal contract award to Luminex Corp is for the provision of reagents for an analyzer. The $41,461.00 firm fixed-price delivery order was awarded on October 1, 2025 by the Veterans Integrated Service Network 5, a civilian agency, with a performance period ending on September 30, 2026. The contract was not set aside for any socioeconomic categories. Luminex Corp is a foreign-owned, for-profit manufacturer of advanced biological testing technologies, and has received numerous federal...
- The Department of Veterans Affairs Veterans Health Administration awarded a $466,426.44 firm-fixed-price purchase order contract to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies, to provide VERIGENE REGENTS. This contract is not set aside. Luminex is a provider of proprietary multiplex diagnostic solutions, assays, reagents, and related products to government customers including the Department of Veterans Affairs, Centers for Disease Control and...
- This is a $82,472 firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs to Luminex Corp, a manufacturer of biological testing technologies. The contract is for the delivery of unspecified test kits, with a period of performance running through September 30, 2025. No set-aside designation is indicated. Luminex is a foreign-owned, for-profit organization that provides proprietary multiplexing platforms,...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- 36F79719D0244-36C24122A0144Blanket Purchase Agreement
- 36C24122A0144-36C24124N0596BPA Call
Luminex Corp has been awarded a Blanket Purchase Agreement (BPA) call valued at $92,743.36 for luminex reagents under the GSA Schedule for In Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII). The contract, executed on August 1, 2024, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order from Veterans Integrated Service Network 1 (VISN 1), the Department of Veterans Affairs' regional network serving veterans across multiple northeastern states. No set-aside designation was utilized for this procurement. Luminex Corp, a foreign-owned manufacturer headquartered in Austin, Texas, specializes in multiplex diagnostic solutions and laboratory testing equipment, making it well-suited to support the VA's diagnostic and laboratory testing requirements. This award builds upon Luminex's established relationship with the Department of Veterans Affairs, which maintains a $519,140 BPA for the company's PCR testing services. The BPA call structure enables the VA to efficiently procure advanced diagnostic reagents and related products through an existing contract vehicle, streamlining access to Luminex's comprehensive diagnostic portfolio. As a proven federal contractor with significant contract vehicles across multiple agencies including the Department of Defense, National Institutes of Health, and Centers for Disease Control and Prevention, Luminex Corp demonstrates substantial capability in delivering sophisticated diagnostic products and services to support federal health and laboratory operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($37k) | 11/7/25 | |
| Not listed | Not listed | $130.0k | 4/16/24 |